PMID- 24903343 OWN - NLM STAT- MEDLINE DCOM- 20150528 LR - 20211021 IS - 1875-8312 (Electronic) IS - 1569-5794 (Print) IS - 1569-5794 (Linking) VI - 30 IP - 7 DP - 2014 Oct TI - Progression of diffuse myocardial fibrosis assessed by cardiac magnetic resonance T(1) mapping. PG - 1339-46 LID - 10.1007/s10554-014-0459-z [doi] AB - To evaluate long-term changes in diffuse myocardial fibrosis using cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) and T1 mapping. Patients with chronic stable cardiomyopathy and stable clinical status (n = 52) underwent repeat CMR at a 6 month or greater follow up interval and had LGE and left ventricular (LV) T1 mapping CMR. Diffuse myocardial fibrosis (excluding areas of focal myocardial scar) was assessed by post gadolinium myocardial T1 times. Mean baseline age of 52 patients (66 % male) was 35 +/- 19 years with a mean interval between CMR examinations of 2.0 +/- 0.8 years. CMR parameters, including LV mass and ejection fraction, showed no change at follow-up CMR (p > 0.05). LVT1 times (excluding focal scar) decreased over the study interval (from 468 +/- 106 to 434 +/- 82 ms, p = 0.049). 38 Patients had no visual LGE-, while 14 were LGE+. For LGE- patients, greater change in LV mass and end systolic volume index were associated with change in T1 time (beta = -2.03 ms/g/m(2), p = 0.035 and beta = 2.1 ms/mL/m(2), p = 0.029, respectively). For LGE+ patients, scar size was stable between CMR1 and CMR2 (10.7 +/- 13.8 and 11.5 +/- 13.9 g, respectively, p = 0.32). These results suggest that diffuse myocardial fibrosis, as assessed by T1 mapping, progresses over time in patients with chronic stable cardiomyopathy. FAU - Yi, Colin J AU - Yi CJ AD - Radiology and Imaging Sciences, National Institutes of Health, 10 Center Drive, Rm 10/1C355, Bethesda, MD, 20892, USA. FAU - Yang, Eunice AU - Yang E FAU - Lai, Shenghan AU - Lai S FAU - Gai, Neville AU - Gai N FAU - Liu, Chia AU - Liu C FAU - Liu, Songtao AU - Liu S FAU - Zimmerman, Stefan L AU - Zimmerman SL FAU - Lima, Joao A C AU - Lima JA FAU - Bluemke, David A AU - Bluemke DA LA - eng GR - ZIA CL090019-04/Intramural NIH HHS/United States GR - ZIA EB000072-04/Intramural NIH HHS/United States PT - Journal Article DEP - 20140606 PL - United States TA - Int J Cardiovasc Imaging JT - The international journal of cardiovascular imaging JID - 100969716 SB - IM MH - Adolescent MH - Adult MH - Cardiomyopathies/*pathology/physiopathology MH - Chronic Disease MH - Disease Progression MH - Female MH - Fibrosis MH - Humans MH - *Magnetic Resonance Imaging MH - Male MH - Middle Aged MH - Myocardium/*pathology MH - Predictive Value of Tests MH - Stroke Volume MH - Time Factors MH - Ventricular Function, Left MH - Young Adult PMC - PMC4169726 MID - NIHMS602855 EDAT- 2014/06/07 06:00 MHDA- 2015/05/29 06:00 PMCR- 2015/10/01 CRDT- 2014/06/07 06:00 PHST- 2014/03/18 00:00 [received] PHST- 2014/05/22 00:00 [accepted] PHST- 2014/06/07 06:00 [entrez] PHST- 2014/06/07 06:00 [pubmed] PHST- 2015/05/29 06:00 [medline] PHST- 2015/10/01 00:00 [pmc-release] AID - 10.1007/s10554-014-0459-z [doi] PST - ppublish SO - Int J Cardiovasc Imaging. 2014 Oct;30(7):1339-46. doi: 10.1007/s10554-014-0459-z. Epub 2014 Jun 6.